Results 321 to 330 of about 2,115,183 (392)
Medicina, 1995 Some of the next articles are maybe not open access.
Related searches:
Related searches:
CELSR1 variants are associated with partial epilepsy of childhood
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2022CELSR1 gene, encoding cadherin EGF LAG seven‐pass G‐type receptor 1, is mainly expressed in neural stem cells during the embryonic period. It plays an important role in neurodevelopment. However, the relationship between CELSR1 and disease of the central
Zhengdong Chen +14 more
semanticscholar +1 more source
Facial Asymmetry in Partial Epilepsies
Epilepsia, 1992Summary: Fifty‐six consecutive epileptic patients with partial seizures (30 temporal, 26 extratemporal) and facial asymmetry were studied. Facial asymmetry was compared with EEG, radiologic, and other clinical findings. Thirty patients had a lesional epilepsy whereas 26 were considered cryptogenic.
TINUPER P +7 more
openaire +3 more sources
Interview accuracy in partial epilepsy
Epilepsy & Behavior, 2009The statistical concept of accuracy has never been applied to verify the history data collected on seizure disorders by open format interview. We compared patients'/witnesses' descriptions of epileptic seizures with videotaped seizure characteristics and analyzed the accuracy (ACC), sensitivity (SN), specificity (SP), false-positive rate (FPR), and ...
Ana Gabriela, Besocke +4 more
openaire +2 more sources
Vigabatrin for refractory partial epilepsy
Cochrane Database of Systematic Reviews, 2008Epilepsy is a common neurological condition which affects between 0.5% and 1% of the population. Approximately 30% of people with epilepsy do not respond to treatment with currently available drugs, and the majority of these people have partial epilepsy. Vigabatrin is an antiepileptic drug licensed for use in the treatment of refractory epilepsy.
Karla, Hemming +3 more
openaire +3 more sources
Felbamate in refractory partial epilepsy
Epilepsy Research, 1999This open-label study was performed to evaluate efficacy and safety of Felbamate (FBM) add-on therapy in drug-refractory partial epilepsy. We evaluated 36 patients (12 males) aged 11-68 years (mean 29.8) in which FBM was titrated gradually from 300 mg/day to a mean total maintenance daily dose of 1936 mg.
R. Canger +3 more
openaire +2 more sources
Benign partial epilepsies in infancy
Brain and Development, 2000Benign partial epilepsies are not rare in infancy and comprise two forms, although both are closely related. One is partial epilepsy with complex partial seizures (CPS) and the other one with secondarily generalized seizures (SGS). The most frequent site of seizure origin was in the temporal area in the former and central, parietal or occipital area in
K, Watanabe, A, Okumura
openaire +2 more sources
Partial epilepsy with “ecstatic” seizures
Epilepsy & Behavior, 2003Reports focusing on auras of ecstasy or pleasure have been limited largely to single case descriptions. We examined 11 consecutive patients with such ictal symptoms. Eight had sensory hallucinations, four had erotic sensations, five described "a religious/spiritual experience," and several had symptoms that were felt to have no counterpart in human ...
Bjørn, Asheim Hansen, Eylert, Brodtkorb
openaire +2 more sources
The Benign Partial Nonrolandic Epilepsies
Journal of Clinical Neurophysiology, 1991Although rolandic epilepsy is the only epileptic syndrome that, at present, fully meets all the criteria of benignity and is widely recognized as such, there are also other forms of partial epilepsy that are benign. These are also genetically determined and age-dependent, occurring in neurologically intact children older than 18 months of age.
P, Lerman, S, Kivity
openaire +2 more sources